Listing 1 - 6 of 6 |
Sort by
|
Choose an application
Choose an application
Sickle cell disease (SCD) is a severe chronic illness and one of the world’s most common genetic conditions, with 400,000 children born annually with the disorder, mainly in Sub-Saharan Africa, India, Brazil, the Middle East and in diasporic African populations in North America and Europe. Biomedical treatments for SCD are increasingly available to the world’s affluent populations, while such medical care is available only in attenuated forms in Africa, India and to socio-economically disadvantaged groups in North America and Europe.Often a condition rendered invisible in policy terms because of its problematic association with politically marginalized groups, the social study of sickle cell has been neglected. This illuminating volume explores the challenges and possibilities for developing a social view of sickle cell, and for improving the quality of lives of those living with SCD. Tackling the controversial role of screening and genetics in SCD, the book offers a brief thematic history of approaches to the condition, queries the role of ethnicity and includes a discussion of how the social model of disability can be applied, as well as featuring chapters focusing on athletics, prisons and schools.Bringing together a wide range of original research conducted in the USA, the UK, Ghana and Nigeria, Sickle Cell and the Social Sciences is anchored in the discipline of sociology, but draws upon a diverse range of fields, including public health, anthropology, social policy and disability studies.
Sickle cell anemia --- Sickle cell anemia --- Sickle cell anemia --- Sickle cell anemia --- Treatment --- Social aspects --- Genetic aspects --- Epidemiology
Choose an application
Demographic surveys --- Sickle cell anemia in children --- Sickle cell anemia --- Diagnosis
Choose an application
Demographic surveys --- Sickle cell anemia in children --- Sickle cell anemia --- Diagnosis
Choose an application
"Sickle cell disease (SCD) is a genetic condition that affects approximately 100,000 people in the United States and millions more globally. Individuals with SCD endure the psychological and physiological toll of repetitive pain as well as side effects from the pain treatments they undergo. Some adults with SCD report reluctance to use health care services, unless as a last resort, due to the racism and discrimination they face in the health care system. Additionally, many aspects of SCD are inadequately studied, understood, and addressed. Addressing Sickle Cell Disease examines the epidemiology, health outcomes, genetic implications, and societal factors associated with SCD and sickle cell trait (SCT). This report explores the current guidelines and best practices for the care of patients with SCD and recommends priorities for programs, policies, and research. It also discusses limitations and opportunities for developing national SCD patient registries and surveillance systems, barriers in the healthcare sector associated with SCD and SCT, and the role of patient advocacy and community engagement groups." --
Sickle cell anemia. --- Medical Technology --- Medicine --- Diseases --- Medical
Choose an application
Quatrième de couverture : Les ouvrages de la collection Pedia sont écrits par les spécialistes du domaine pour les pédiatres hospitaliers et libéraux les internes des services de pédiatrie ainsi que pour les médecins généralistes et parfois des spécialistes de médecine pour adulte.Précis et didactiques ils fournissent à ces praticiens : les éléments indispensables pour détecter et reconnaître les pathologies ; des réponses claires à des situations cliniques précises ; des critères d’orientation et des propositions de conduites à tenir. Maladie héréditaire de l’hémoglobine la drépanocytose touche plus de cinq millions de personnes à travers le monde et est actuellement considérée comme la maladie monogénique la plus répandue. De sévérité et d’évolution très variables les manifestations de la drépanocytose sont multiples : anémie crises vaso-occlusives douloureuses accidents vasculaires cérébraux susceptibilité accrue aux infections méningites et ostéomyélites notamment atteintes chroniques d’organe. En France grâce à une prise en charge précoce la drépanocytose n’entraîne désormais qu’une exceptionnelle mortalité dans l’enfance contrastant cependant avec une importante morbidité. Pour répondre aux besoins des pédiatres et médecins généralistes qui dans leur pratique quotidienne peuvent être amenés à prendre en charge ces patients l’ouvrage fait le point sur la drépanocytose « vie entière » les situations d’urgence les atteintes chroniques d’organe et la thérapeutique."
Drépanocytose. --- Enfants --- Adolescents --- Drépanocytose --- Maladies. --- Enfant. --- Adolescent. --- Sickle cell anemia in children --- Anemia, Sickle Cell --- Child --- Adolescent --- Sickle Cell Trait --- Child Care --- therapy --- Hematologic Diseases --- Anemia, Hemolytic, Congenital --- Genetic Diseases, Inborn --- Pediatrics --- Sickle Cell Trait - therapy --- Genetic Diseases, Inborn. --- Pediatrics. --- Child. --- Anemia, Sickle Cell. --- Anemia, Hemolytic, Congenital.
Listing 1 - 6 of 6 |
Sort by
|